ArticleReproductive health2022

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol.

Xin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.